A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer

다국어 초록 (Multilingual Abstract)

Purpose: A chemosensitivity test can reflect the differences in responses of individual cancer patients to chemotherapeutic agents. The adenosine triphosphatebasedchemotherapy response assay (ATP-CRA)is an accurate method, which does not require a large amount of tissue specimen. So far, no studies have evaluated the utility of the ATP-CRA in Korea. Therefore, we investigated the clinical usefulness of the ATP-CRA in 53 patients with lung cancer.Materials and Methods: Tumor tissues were obtained from bronchoscopic biopsies or surgical resections. The validity of ATP-CRA was assessed focusing on the success rate, experimental error level (intraassay mean coefficient of variation [CV]) and reproducibility.Results: The overall success rate of ATP-CRA was 90.6% (48/53). Normal cells were effectively eliminated from the tumor tissues with the use of ficoll gradient centrifugation and immunomagnetic separation, which was confirmed using loss of heterozygosity analysis of the 3p deletion. The mean CV of ATP assays was 10.5± 4.6%. The reproducibility of ATP assays was 94±3.8%. The results of the ATP assays were reported to physicians within 7 days of specimen collection. More than 6 anticancer drugs were tested on the tumor specimens obtained from bronchoscopic biopsies.Conclusion: The ATP-CRA is a stable, accurate and potentially practical chemosensitivity test in patients with lung cancer.

참고문헌 (Reference)

1 "Tumor tissue is more sensitive to mitomycin C and aclacinomycin A than is adjacent normal tissue in vitro" 4-7, 1989

2 "The usefulnessof the ATP assay with serum-free culture for chemosensitivitytesting of gastrointestinal cancer" 33 : 960-6, 1997

3 "The ex vivo chemosensitivity profile of choroidalmelanoma" 8 : 756-62, 1997

4 "The Reliabilityof histoculture drug response assay (HDRA) in chemosensitivitytest for breast cancer." 33 : 392-7, 2001

5 "The ATP assayis more sensitive than the succinate dehydrogenase inhibitiontest for predicting cell viability" 23 : 273-6, 1987

6 "Review of the efficacy of individualizedchemotherapy selected by in vitro drug sensitivity testingfor patients with cancer" 17 : 1625-31, 1999

7 "Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs" 298 : 1321-7, 1978

8 "Principles andpractice of oncology 6th ed." Lippincott Williams& Wilkins 303-, 2001

9 "Predictive value of the ATP chemosensitivityassay in epithelial ovarian cancer" 83 : 334-42, 2001

10 "Outcome of ATP-based tumorchemosensitivity assay directed chemotherapy in heavilypre-treated recurrent ovarian carcinoma" 3 : 19-, 2003

11 "Intra-arterial mitoxantrone and paclitaxel ina patient with Stewart-Treves syndrome:selection of chemotherapyby an ex vivo ATP-based chemosensitivity assay" 11 : 269-73, 2000

12 "Individualizing chemotherapy for solidtumors-is there any alternative" 8 : 541-8, 1997

13 "Individualizedlong-term chemotherapy for recurrent ovarian cancerafter failing high-dose treatment" 13 : 173-6, 2002

14 "Heterogeneity of chemosensitivity of metastatic cutaneousmelanoma" 10 : 437-44, 1999

15 "Correlation of the clinical response tochemotherapy in breast cancer with ex vivo chemosensitivity" 7 : 630-5, 1996

16 "Correlation of drug response with the ATP tumorchemosensitivityassay in primary FIGO stage III ovariancancer" 77 : 258-63, 2000

17 "Comparisonof MTT and ATP-based assays for the measurement of viablecell number" 10 : 29-34, 1995

18 "Clinical utilityof adenosine triphosphate-based chemosensitivity response assay(ATP-CRA) in non-small cell lung cancer: preliminarystudy" 23 : 677-, 2004

19 "Clinical applicabilityof the ATP cell viability assay as a predictor of chemoresponsein platinum-resistant epithelial ovarian cancer usingnonsurgical tumor cell samples" 76 : 405-8, 2000

20 "Cisplatin-based adjuvant chemotherapy in patients withcompletely resected non-small-cell lung cancer" 350 : 351-60, 2004

21 "Chemosensitivity testing with highly purifiedfresh human tumour cells with the MTT colorimetric assay" 7 : 1258-63, 1991

22 "Chemosensitivity testing of human tumorsusing a microplate adenosine triphosphate luminescence assay:clinical correlation for cisplatin resistance of ovarian carcinoma" 55 : 5276-82, 1995

23 "Chemosensitivity testing in oncology" Springer-Verlag 126-45, 2003

24 "Annual Report of Death StatisticsData in 2003" National Statistics Office.

25 "A randomized trial of adjuvant chemotherapy with uraciltegafurfor adenocarcinoma of the lung" 350 : 1713-21, 2004